Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Congenital Adrenal Hyperplasia

Endocrine & Hormonal

Congenital Adrenal Hyperplasia (CAH) Clinical Trials

Also called CAH, 21-hydroxylase deficiency, adrenogenital syndrome

Congenital adrenal hyperplasia (CAH) comprises rare autosomal recessive disorders of cortisol and aldosterone synthesis resulting from enzymatic defects in the steroidogenic pathway. Over 90% result from deficiency of 21-hydroxylase (CYP21A2 gene mutations), with remaining cases due to 11-beta-hydroxylase, 3-beta-hydroxysteroid dehydrogenase, or lipoid CAH.

In plain words, congenital adrenal hyperplasia is a group of inherited conditions in which the body cannot make enough of a hormone called cortisol. Depending on the form, this can upset the body's salt balance or cause early puberty and unusual growth.

Get an email when new Congenital Adrenal Hyperplasia trials open or the FDA decides. Get alerts

Congenital Adrenal Hyperplasia

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 13 studies with no phase, like observational studies, and 1 phase 4 study following medicines after approval.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines3

Crenessity · Corticosteroids · Fludrocortisone acetate

Congenital Adrenal Hyperplasia has 3 FDA-approved medicines, 22 open or active clinical trials (15 recruiting), and no pending FDA decision.

Labels checked October 21, 2026. Corticosteroids and immune globulins count once each.Download the data

Latest for Congenital Adrenal Hyperplasia

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Congenital Adrenal Hyperplasia

The 21-hydroxylase enzyme deficiency blocks cortisol synthesis at a critical step, causing shunting of precursors into androgen production, resulting in excessive androgens and combined glucocorticoid and mineralocorticoid deficiency. Three distinct clinical phenotypes exist: salt-wasting (most severe, presenting at 1-4 weeks with hyponatremia, hyperkalemia, and circulatory collapse), simple virilizing (androgen excess without salt wasting, manifesting at birth or early childhood), and non-classic (mild or late-onset androgen excess).

Keep reading about Congenital Adrenal Hyperplasia

Newborn females with classic forms show external virilization including clitoromegaly, labial fusion, and potential ambiguous genitalia. Males may present with precocious puberty or salt-wasting crisis. Without treatment, salt-wasting CAH is life-threatening; all forms require lifelong hormone replacement and monitoring.

What are the symptoms of Congenital Adrenal Hyperplasia?

These are common symptoms of Congenital Adrenal Hyperplasia, and how strong they are varies from person to person.

  • Genitals that look more male-typical in female newborns (virilization)
  • Salt-wasting crisis in severe forms (hyponatremia, hyperkalemia)
  • Precocious puberty and rapid growth in males
  • Accelerated linear growth in childhood
  • Acne and male-pattern baldness
  • Infertility and reproductive dysfunction

Who gets Congenital Adrenal Hyperplasia?

CAH shows autosomal recessive inheritance, affecting males and females equally across all populations. MedlinePlus Genetics puts the classic form at about 1 in 15,000 newborns and the milder non-classic form at about 1 in 1,000 people, and both vary by population. NORD reports the highest known rate among the Yupik people of Alaska, where the salt-wasting form may affect as many as 1 in 282.

Manifestations appear in neonates and early infants (salt-wasting forms) or early childhood (simple virilizing forms). Non-classic forms may present in adolescence or adulthood during reproductive years, particularly in females with irregular menses or hirsutism. Genetic counseling indicates 25% recurrence risk in subsequent pregnancies if both parents are identified carriers.

Next steps: find trials you might fitsee approved treatmentsget help payingget alerts

Which medicines are FDA-approved for Congenital Adrenal Hyperplasia?

There are currently 3 FDA-approved medications for Congenital Adrenal Hyperplasia.

crinecerfont
Neurocrine Biosciences
Search
Corticosteroids
hydrocortisone, cortisone, prednisone, prednisolone, methylprednisolone, dexamethasone, betamethasone, triamcinolone
Fludrocortisone acetate
fludrocortisone acetate

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

How to get help paying for Congenital Adrenal Hyperplasia treatment

Charity funds and drugmaker programs for Congenital Adrenal Hyperplasia, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Congenital Adrenal Hyperplasia

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Congenital Adrenal Hyperplasia resources

Reputable organizations and medical references for learning more about Congenital Adrenal Hyperplasia, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Congenital Adrenal Hyperplasia

Use this Congenital Adrenal Hyperplasia clinical trial finder to see the 15 studies recruiting patients and 7 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 10 test a treatment and 12 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

22 active trials worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenRecently updatedNCT00250159

Natural History Study of Patients With Excess Androgen

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe problems associated with it. Too much androgen in childhood, if untreated, results ...

Ages 1 Day to 99 Years1 location
Started Jan 2006Updated 6 days agoCompletion date not listed
RecruitingTreatment trialPhase 2/3Recently updatedNCT07159841

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Intervention: Atumelnant, Placebo

Sponsor: Crinetics Pharmaceuticals Inc.

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).

Ages 1 Year to 17 Years
Started Jan 2026Updated 1 week agoEst. Mar 2030 (~3y 4m)
RecruitingTreatment trialPhase 3Recently updatedNCT07144163

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Intervention: Atumelnant, Placebo

Sponsor: Crinetics Pharmaceuticals Inc.

The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD.

Ages 18 Years to 74 Years
Started Dec 2025Updated 1 week agoEst. May 2027 (~6 months)
RecruitingPatient registry covering many conditionsRecently updatedNCT07920198

Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)

Sponsor: Azienda Ospedaliero-Universitaria di Modena

Primary Objective: The primary objective of the study is to characterize subjects affected by adrenal disease by collecting medical history data at diagnosis, clinical, bio-humoral, and radiological data, as well as information regarding the therapeutic approach, in terms of both...

Ages 18 Years+1 location
Started Jul 2026Updated 1 week agoEst. Feb 2030 (~3y 2m)
Not yet recruitingObservational study, no treatment givenRecently updatedNCT07611786

Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia

Intervention: exposure to healthcare transition protocol

Sponsor: University of Alabama at Birmingham · Neurocrine Biosciences

The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on tra...

Ages 16 Years+1 location
Expected to start Jan 2027Updated 1 month agoEst. Dec 2028 (~2y 1m)
Find Congenital Adrenal Hyperplasia trials near you, ranked by distance →
Active trial locations26 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+18 more

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Phase 3
Phase 4
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Congenital Adrenal Hyperplasia trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Congenital Adrenal Hyperplasia foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Congenital Adrenal Hyperplasia patient communities

Facebook groups, Reddit communities and YouTube channels where Congenital Adrenal Hyperplasia patients, caregivers and advocacy groups talk.

Companies developing Congenital Adrenal Hyperplasia treatments

Drugmakers that list Congenital Adrenal Hyperplasia in their rare disease portfolio, 4 in all.

Questions people ask about Congenital Adrenal Hyperplasia